Literature DB >> 11300626

Update: assessment of risk for meningococcal disease associated with the Hajj 2001.

.   

Abstract

During late March and early April 2000, four cases of meningococcal disease caused by Neisseria meningitidis serogroup W-135 were identified among U.S. pilgrims returning from the Hajj in Saudi Arabia, their close contacts, and communities. These cases occurred as part of a larger epidemic in which approximately 400 cases caused by a similar and unusual strain were identified worldwide. The Hajj, an annual pilgrimage to the major holy places of Islam, is attended by approximately two million persons from approximately 140 countries, including an estimated 15,000 from the United States.

Entities:  

Mesh:

Year:  2001        PMID: 11300626

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  12 in total

1.  The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey.

Authors:  Rahmi Tuna Tekin; Ener Cagri Dinleyici; Mehmet Ceyhan; Adem Karbuz; Nuran Salman; Murat Sutçu; Zafer Kurugol; Yasemin Balliel; Melda Celik; Mustafa Hacimustafaoglu; Necdet Kuyucu; Meda Kondolot; Gülnar Sensoy; Ozge Metin; Soner Sertan Kara; Meltem Dinleyici; Omer Kılıç; Cihangul Bayhan; Venhar Gurbuz; Emre Aycan; Aygun Memedova; Arzu Karli; Gulçin Bozlu; Solmaz Celebi
Journal:  Hum Vaccin Immunother       Date:  2017-01-31       Impact factor: 3.452

2.  Hajj-related Neisseria meningitidis serogroup w135 in Mauritius.

Authors:  Mohammad Iqbal Issack; Chinien Ragavoodoo
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

3.  Recent Advances and New Challenges in Travel Medicine.

Authors:  Lin H. Chen; Mary E. Wilson
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.663

4.  Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.

Authors:  Annelies Wilder-Smith; Timothy M S Barkham; Sindhu Ravindran; Arul Earnest; Nicholas I Paton
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

5.  Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011.

Authors:  Gisselle N Barra; Pamela A Araya; Jorge O Fernandez; Jean-Marc Gabastou; Juan Carlos Hormazábal; Mabel Seoane; Paola C Pidal; Maria T Valenzuela; Ana Belén Ibarz-Pavón
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

6.  Neisseria meningitidis W135, Turkey.

Authors:  Levent Doganci; Mehmet Baysallar; Mehmet Ali Saracli; Gulsen Hascelik; Alaaddin Pahsa
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

7.  Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease.

Authors:  Sanford R Kimmel
Journal:  Ther Clin Risk Manag       Date:  2008-08       Impact factor: 2.423

8.  A prospective study of etiology of childhood acute bacterial meningitis, Turkey.

Authors:  Mehmet Ceyhan; Inci Yildirim; Paul Balmer; Ray Borrow; Bunyamin Dikici; Mehmet Turgut; Nese Kurt; Aysel Aydogan; Cigdem Ecevit; Yasar Anlar; Ozlem Gulumser; Gonul Tanir; Nuran Salman; Nezahat Gurler; Nevin Hatipoglu; Mustafa Hacimustafaoglu; Solmaz Celebi; Yavuz Coskun; Emre Alhan; Umit Celik; Yildiz Camcioglu; Gulten Secmeer; Deniz Gur; Steve Gray
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

Review 9.  Prevention of infectious diseases among international pediatric travelers: considerations for clinicians.

Authors:  Susan A Maloney; Michelle Weinberg
Journal:  Semin Pediatr Infect Dis       Date:  2004-07

10.  Serogroup W-135 meningococcal disease during the Hajj, 2000.

Authors:  Jairam R Lingappa; Abdullah M Al-Rabeah; Rana Hajjeh; Tajammal Mustafa; Adel Fatani; Tami Al-Bassam; Amira Badukhan; Abdulhafiz Turkistani; Sahar Makki; Nassen Al-Hamdan; Mohamed Al-Jeffri; Yaqoub Al Mazrou; Bradley A Perkins; Tonja Popovic; Leonard W Mayer; Nancy E Rosenstein
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.